Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors
BOSTON, June 08, 2018 -- (Healthcare Sales & Marketing Network) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the election of Anne Klibanski, M.D., and ... Biopharmaceuticals, Gastroenterology, Personnel Albireo Pharma, bile acid modulator, liver disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Bile | Gastroenterology | Liver | Liver Disease | Marketing | Pediatrics | Pharmaceuticals | Urology & Nephrology